St. Louis Post Dispatch - A St. Louis lawyer has secured the right to proceed with a national class-action lawsuit that could pit more than 440,000 U.S. corn farmers against Switzerland-based seed giant Syngenta.
The National Law Review – The decision in EEOC v. Orion Energy Systems, Inc. decision suggests that employers should continue to take the new EEOC regulations on wellness plans into account for 2017 and beyond.
Futurism - Agriculture giant Monsanto has licensed CRISPR-Cas9 genome-editing technology from the Broad Institute for use in seed development. There are a few caveats to the agreement, including non-inclusion in the controversial gene drive.
The Huffington Post - When I was a teenager, my mom miraculously survived ovarian cancer (at a time when most women didn’t), and my aunt died of it. So once the genetic testing became available, my mom tested positive for the BRCA 1 gene mutation.
STATnews' The Readout - Last night, there’s was a lot of talk about cybering, NAFTA, Rosie O’Donnell, and other key aspects of the '90s zeitgeist. But there was nary a mention of healthcare, biopharma, or really anything that pertains science.
The Daily Progress / Associated Press – Connecticut hasn't become the Silicon Valley of bioscience, but five years after lawmakers made a massive investment to support the development of that industry, there is a thriving hub at the University of Connecticut.
GenomeWeb – Direct-to-consumer genetic testing firms are often not completetly upfront about how they keep their customers' information confidential and private and how they might use their data in research.
Sunday Start Times - New Zealand's Law Commission will review The Criminal Investigations (Bodily Samples) Act 1995, through consultation with those who currently are using the legislation, such as police, judges and lawyers.